Back to Journals » ClinicoEconomics and Outcomes Research » Volume 11

Cost-effectiveness of fractional exhaled nitric oxide (FeNO) measurement in predicting response to omalizumab in asthma

Total article views   HTML views PDF downloads Totals
13,327 Dovepress* 12,248+ 1,693 13,941
PubMed Central* 1,079 285 1,364
Totals 13,327 1,978 15,305
*Since 17 April 2019

View citations on PubMed Central and Google Scholar